[English] 日本語
Yorodumi- PDB-9j9d: Crystal structure of ALK5 kinase domain in complex with inhibitor... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 9j9d | ||||||
|---|---|---|---|---|---|---|---|
| Title | Crystal structure of ALK5 kinase domain in complex with inhibitor HM-279 | ||||||
Components | TGF-beta receptor type-1 | ||||||
Keywords | ONCOPROTEIN / Protein kinase / Inhibitor complex | ||||||
| Function / homology | Function and homology informationextracellular structure organization / epicardium morphogenesis / vascular endothelial cell proliferation / parathyroid gland development / transforming growth factor beta ligand-receptor complex / regulation of cardiac muscle cell proliferation / myofibroblast differentiation / positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation / TGFBR2 Kinase Domain Mutants in Cancer / transforming growth factor beta receptor activity ...extracellular structure organization / epicardium morphogenesis / vascular endothelial cell proliferation / parathyroid gland development / transforming growth factor beta ligand-receptor complex / regulation of cardiac muscle cell proliferation / myofibroblast differentiation / positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation / TGFBR2 Kinase Domain Mutants in Cancer / transforming growth factor beta receptor activity / trophoblast cell migration / angiogenesis involved in coronary vascular morphogenesis / SMAD2/3 Phosphorylation Motif Mutants in Cancer / TGFBR1 KD Mutants in Cancer / positive regulation of mesenchymal stem cell proliferation / ventricular compact myocardium morphogenesis / positive regulation of extracellular matrix assembly / positive regulation of tight junction disassembly / TGFBR3 regulates TGF-beta signaling / cardiac epithelial to mesenchymal transition / mesenchymal cell differentiation / transforming growth factor beta receptor activity, type I / positive regulation of vasculature development / neuron fate commitment / activin receptor complex / activin receptor activity, type I / regulation of epithelial to mesenchymal transition / type II transforming growth factor beta receptor binding / pharyngeal system development / transmembrane receptor protein serine/threonine kinase activity / receptor protein serine/threonine kinase / activin binding / TGFBR1 LBD Mutants in Cancer / germ cell migration / filopodium assembly / coronary artery morphogenesis / embryonic cranial skeleton morphogenesis / activin receptor signaling pathway / ventricular trabecula myocardium morphogenesis / response to cholesterol / I-SMAD binding / transforming growth factor beta binding / collagen fibril organization / negative regulation of chondrocyte differentiation / lens development in camera-type eye / endothelial cell activation / anterior/posterior pattern specification / positive regulation of filopodium assembly / artery morphogenesis / skeletal system morphogenesis / ventricular septum morphogenesis / SMAD binding / negative regulation of endothelial cell proliferation / TGF-beta receptor signaling activates SMADs / roof of mouth development / positive regulation of SMAD protein signal transduction / blastocyst development / epithelial to mesenchymal transition / regulation of protein ubiquitination / bicellular tight junction / endothelial cell migration / cellular response to transforming growth factor beta stimulus / positive regulation of epithelial to mesenchymal transition / positive regulation of stress fiber assembly / positive regulation of endothelial cell proliferation / transforming growth factor beta receptor signaling pathway / negative regulation of cell migration / thymus development / Downregulation of TGF-beta receptor signaling / positive regulation of apoptotic signaling pathway / TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) / post-embryonic development / skeletal system development / negative regulation of extrinsic apoptotic signaling pathway / kidney development / cell motility / wound healing / peptidyl-serine phosphorylation / cellular response to growth factor stimulus / male gonad development / UCH proteinases / nervous system development / heart development / regulation of gene expression / positive regulation of cell growth / in utero embryonic development / positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction / receptor complex / protein kinase activity / regulation of cell cycle / endosome / Ub-specific processing proteases / intracellular signal transduction / cilium / positive regulation of cell migration / membrane raft / protein serine/threonine kinase activity / positive regulation of cell population proliferation / apoptotic process / ubiquitin protein ligase binding Similarity search - Function | ||||||
| Biological species | Homo sapiens (human) | ||||||
| Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 1.337 Å | ||||||
Authors | Arai, M. / Hanada, M. / Taniguchi, H. / Ohmoto, H. / Naka, K. / Sawa, M. | ||||||
| Funding support | 1items
| ||||||
Citation | Journal: J.Med.Chem. / Year: 2025Title: Discovery of HM-279, a Potent Inhibitor of ALK5 for Improving Therapeutic Efficacy of Cancer Immunotherapy. Authors: Arai, M. / Hanada, M. / Taniguchi, H. / Nakajima, F. / Ohmoto, H. / Inoue, T. / Naka, K. / Sawa, M. | ||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 9j9d.cif.gz | 84.9 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb9j9d.ent.gz | Display | PDB format | |
| PDBx/mmJSON format | 9j9d.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 9j9d_validation.pdf.gz | 697.3 KB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 9j9d_full_validation.pdf.gz | 699.9 KB | Display | |
| Data in XML | 9j9d_validation.xml.gz | 17.3 KB | Display | |
| Data in CIF | 9j9d_validation.cif.gz | 24 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/j9/9j9d ftp://data.pdbj.org/pub/pdb/validation_reports/j9/9j9d | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 2wouS S: Starting model for refinement |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||
| Unit cell |
|
-
Components
| #1: Protein | Mass: 34953.223 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: TGFBR1, ALK5, SKR4 / Production host: ![]() References: UniProt: P36897, receptor protein serine/threonine kinase | ||||||
|---|---|---|---|---|---|---|---|
| #2: Chemical | ChemComp-A1L30 / Mass: 451.545 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: C22H25N7O2S / Feature type: SUBJECT OF INVESTIGATION | ||||||
| #3: Chemical | ChemComp-EDO / #4: Water | ChemComp-HOH / | Has ligand of interest | Y | Has protein modification | N | |
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 2.06 Å3/Da / Density % sol: 40.28 % |
|---|---|
| Crystal grow | Temperature: 277 K / Method: vapor diffusion, sitting drop / pH: 8.5 Details: 20-25% PEG8000, 0.2 M Na acetate, 0.1 M Tris-HCl pH8.5 |
-Data collection
| Diffraction | Mean temperature: 100 K / Serial crystal experiment: N |
|---|---|
| Diffraction source | Source: SYNCHROTRON / Site: SPring-8 / Beamline: BL44XU / Wavelength: 0.9 Å |
| Detector | Type: DECTRIS EIGER X 16M / Detector: PIXEL / Date: May 25, 2023 |
| Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
| Radiation wavelength | Wavelength: 0.9 Å / Relative weight: 1 |
| Reflection | Resolution: 1.337→50 Å / Num. obs: 66655 / % possible obs: 99.2 % / Redundancy: 3.52 % / CC1/2: 0.998 / Net I/σ(I): 12.6 |
| Reflection shell | Resolution: 1.337→1.42 Å / Num. unique obs: 20131 / CC1/2: 0.727 |
-
Processing
| Software |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: MOLECULAR REPLACEMENTStarting model: 2WOU Resolution: 1.337→44.813 Å / Cor.coef. Fo:Fc: 0.959 / Cor.coef. Fo:Fc free: 0.949 / SU B: 0.883 / SU ML: 0.037 / Cross valid method: FREE R-VALUE / ESU R: 0.059 / ESU R Free: 0.059 Details: Hydrogens have been added in their riding positions
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Ion probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.2 Å / Solvent model: MASK BULK SOLVENT | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters | Biso mean: 12.503 Å2
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: LAST / Resolution: 1.337→44.813 Å
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell | Refine-ID: X-RAY DIFFRACTION / Total num. of bins used: 20
|
Movie
Controller
About Yorodumi



Homo sapiens (human)
X-RAY DIFFRACTION
Citation
PDBj








